Pathogen reduction of whole blood: utility and feasibility

Transfusion Medicine

Volumn 27, Issue 5, 2017, Pages 320-326

  Allain, J P ^a   Goodrich, R ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

developing countries; pathogen reduction; sub Saharan Africa; whole blood

Indexed keywords

AFRICA SOUTH OF THE SAHARA; BLOOD BANK; BLOOD CELL; BLOOD SAFETY; DEVELOPING COUNTRY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MEDLINE; MIDDLE INCOME COUNTRY; NONHUMAN; PARASITE; PATHOGEN LOAD; PLASMODIUM FALCIPARUM; SYSTEMATIC REVIEW; VIRUS; BLOOD COMPONENT THERAPY; DISINFECTION; PROCEDURES;

AFRICA SOUTH OF THE SAHARA; BLOOD COMPONENT TRANSFUSION; BLOOD SAFETY; DISINFECTION; HUMANS;

EID: 85032301805     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12456     Document Type: Review

References (38)

1. Adjei, A.A., Kuma, G.K., Tettey, Y. et al. (2009) Bacterial contamination of blood and blood components in three major blood transfusion centers, Accra, Ghana. Japanese Journal of Infectious Diseases, 62, 265–269.
2. Ala, F., Allain, J.P., Bates, I. et al. (2012) External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Medicine, 9, e1001309.
3. Allain, J.P. (2011) Moving on from voluntary non-remunerated donors: who is the best blood donor? British Journal of Haematology, 154, 763–769.
4. Allain, J.P., Assennato, S.M., Osei, E.N. et al. (2016a) Characterization of posttransfusion plasmodium falciparum infection in semi-immune nonparasitemic patients. Transfusion, 56, 2374–2383.
5. Allain, J.P., Owusu-Ofori, A.K., Assennato, S.M. et al. (2016b) Effect of plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African investigation of the Mirasol system (AIMS) randomised controlled trial. Lancet, 387, 1753–1761.
6. Bates, I., Manyasi, G. & Medina, L.A. (2007) Reducing replacement donors in sub-Saharan Africa: challenges and affordability. Transfusion Medicine, 17, 434–442.
7. Burnouf, T., Radosevich, M., El-Ekiaby, M. & Goubran, H. (2011) Pathogen reduction technique for fresh-frozen plasma, cryoprecipitate, and plasma fraction minipools prepared in disposable processing bag systems. Transfusion, 51, 446–447.
8. Butler, E.K., Hume, H., Birungi, I. et al. (2015) Blood utilization at a national referral hospital in sub-Saharan Africa. Transfusion, 55, 1058–1066.
9. Cancelas, J.A., Rugg, N., Fletcher, D. et al. (2011) In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion, 51, 1460–1468.
10. Cancelas, J.A., Slichter, S.J., Rugg, N. et al. (2017) Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage. Transfusion, 57, 1218–1225.
11. Cap, A.P., Pidcoke, H.F., Keil, S.D., Staples, H.M. et al. (2016) Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro. Transfusion, 56 (Suppl. 1), S6–15.
12. Corash, L. & Benjamin, R.J. (2016) The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet a pathogen reduction treatment model. Transfusion, 56 (Suppl. 1), S29–S38.
13. El Chaar, M., Atwal, S., Freimanis, G.L., Dinko, B., Sutherland, C.J. & Allain, J.P. (2013) Inactivation of plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion, 53, 3174–3183.
14. Fast, L.D., Nevola, M., Tavares, J., Reddy, H.L., Goodrich, R.P. & Marschner, S. (2013) Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion, 53, 373–381.
15. Freimanis, G., Sedagah, M., Owusu-Ofori, S., Kumar, S. & Allain, J.P. (2013) Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion, 53, 1429–1441.
16. Gobbini, F., Owusu-Ofori, S., Marcelin, A.G., Candotti, D. & Allain, J.P. (2012) Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion, 52, 2294–2299.
17. Goodrich, R.P., Doane, S. & Reddy, H.L. (2010) Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals, 38, 20–30.
18. Hassall, O., Maitland, K., Pole, L. et al. (2009) Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital. Transfusion, 49, 2594–2598.
19. Hladik, W., Pellett, P.E., Hancock, J. et al. (2012) Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. The Journal of Infectious Diseases, 206, 1497–1503.
20. Jimenez-Marco, T., Cancino-Faure, B., Girona-Llobera, E., Alcover, M.M., Riera, C. & Fisa, R. (2017) The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood. Transfusion, 57, 1440–1447.
21. Kubio, C., Tierney, G., Quaye, T. et al. (2012) Blood transfusion practice in a rural hospital in northern Ghana, Damongo, west Gonja District. Transfusion, 52, 2161–2166.
22. Mafirakureva, N., Nyoni, H., Nkomo, S.Z. et al. (2016) The costs of producing a unit of blood in Zimbabwe. Transfusion, 56, 628–636.
23. Makuni, N., Simango, C. & Mavenyengwa, R.T. (2015) Prevalence of bacterial contamination in blood and blood products at the National Blood Service Zimbabwe. Journal of Infection in Developing Countries, 9, 421–424.
24. Marschner, S. & Goodrich, R. (2011) Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfusion Medicine and Hemotherapy, 38, 8–18.
25. Marschner, S., Fast, L.D., Baldwin, W.M. 3rd, Slichter, S.J. & Goodrich, R.P. (2010) White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion, 50, 2489–2498.
26. Opoku-Okrah, C., Feglo, P., Amidu, N. & Dakorah, M.P. (2009) Bacterial contamination of donor blood at the Tamale teaching hospital, Ghana. African Health Sciences, 9, 13–18.
27. Osei, E.N., Odoi, A.T., Owusu-Ofori, S. & Allain, J.P. (2013) Appropriateness of blood product transfusion in the obstetrics and gynaecology (O&G) department of a tertiary hospital in West Africa. Transfusion Medicine, 23, 160–166.
28. Owusu-Ofori, S., Kusi, J., Owusu-Ofori, A. et al. (2015) Treatment of whole blood with riboflavin and UV light: impact on malaria parasite viability and whole blood storage. Shock, 44 (Suppl. 1), 33–38.
29. Pidcoke, H.F., McFaul, S.J., Ramasubramanian, A.K. et al. (2013) Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion, 53 (Suppl. 1), 137S–149S.
30. Pitman, J.P., Bocking, A., Wilkinson, R. et al. (2015) The impact of external donor support through the U.S. President's emergency plan for AIDS relief on the cost of red cell concentrate in Namibia, 2004-2011. Blood Transfusion, 13, 240–247.
31. Qadri, S.M., Chen, D., Schubert, P. et al. (2017) Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis. Transfusion, 57, 661–673.
32. Reddy, H.L., Doane, S.K., Keil, S.D., Marschner, S. & Goodrich, R.P. (2013) Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion, 53 (Suppl. 1), 131S–136S.
33. Sailliol, A., Ausset, S. & Peytel, E. (2010) Blood transfusion in emergency settings: French military health service experience. Transfusion Clinique et Biologique, 17, 279–283.
34. Schubert, P., Culibrik, B., Karwal, S. et al. (2015) Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method. Transfusion, 55, 815–823.
35. Tonnetti, L., Thorp, A.M., Reddy, H.L., Keil, S.D., Goodrich, R.P. & Leiby, D.A. (2012) Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion, 52, 409–416.
36. Tonnetti, L., Thorp, A.M., Reddy, H.L., Keil, S.D., Goodrich, R.P. & Leiby, D.A. (2013) Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion, 53, 860–867.
37. Tonnetti, L., Thorp, A.M., Reddy, H.L. et al. (2015) Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light. Transfusion, 55, 326–329.
38. Yonemura, S., Doane, S., Keil, S., Goodrich, R., Pidcoke, H. & Cardoso, M. (2017) Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology. Blood Transfusion, 15, 357–364.